Your browser is no longer supported. Please, upgrade your browser.
DGX [NYSE]
Quest Diagnostics Incorporated
IndexS&P 500 P/E11.15 EPS (ttm)10.45 Insider Own0.50% Shs Outstand134.00M Perf Week0.31%
Market Cap15.43B Forward P/E14.83 EPS next Y7.86 Insider Trans-42.92% Shs Float131.67M Perf Month-5.78%
Income1.43B PEG3.28 EPS next Q3.79 Inst Own91.00% Short Float1.91% Perf Quarter-6.24%
Sales9.44B P/S1.63 EPS this Y70.70% Inst Trans-1.06% Short Ratio1.86 Perf Half Y5.96%
Book/sh50.44 P/B2.31 EPS next Y-29.28% ROA10.70% Target Price140.40 Perf Year9.91%
Cash/sh8.75 P/C13.32 EPS next 5Y3.40% ROE23.10% 52W Range73.02 - 134.71 Perf YTD-2.18%
Dividend2.48 P/FCF11.96 EPS past 5Y16.60% ROI13.80% 52W High-13.47% Beta1.01
Dividend %2.13% Quick Ratio1.60 Sales past 5Y4.70% Gross Margin38.20% 52W Low59.64% ATR3.48
Employees40000 Current Ratio1.70 Sales Q/Q55.90% Oper. Margin20.90% RSI (14)39.30 Volatility2.79% 3.07%
OptionableYes Debt/Eq0.59 EPS Q/Q128.60% Profit Margin15.10% Rel Volume1.12 Prev Close115.59
ShortableYes LT Debt/Eq0.59 EarningsFeb 04 BMO Payout20.80% Avg Volume1.35M Price116.57
Recom2.10 SMA20-4.72% SMA50-4.98% SMA200-2.44% Volume1,481,295 Change0.85%
Oct-21-20Upgrade Argus Hold → Buy
Jul-29-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $144
Jul-14-20Upgrade BofA Securities Neutral → Buy $142
Jun-09-20Upgrade Wells Fargo Underweight → Equal Weight $90 → $120
Jun-02-20Upgrade Deutsche Bank Hold → Buy $140
Apr-28-20Upgrade Morgan Stanley Equal-Weight → Overweight $139
Apr-27-20Upgrade Wolfe Research Underperform → Peer Perform
Apr-27-20Upgrade Citigroup Neutral → Buy $113 → $130
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $95
Jan-08-20Initiated Wells Fargo Underweight $100
Jan-07-20Downgrade Barclays Overweight → Equal Weight $106
Dec-19-19Upgrade BofA/Merrill Underperform → Neutral $94 → $110
Jul-15-19Downgrade Goldman Neutral → Sell $90 → $85
Apr-02-19Upgrade Jefferies Hold → Buy $93 → $107
Mar-18-19Resumed Credit Suisse Neutral $101 → $91
Jan-31-19Downgrade Argus Buy → Hold
Jan-17-19Initiated UBS Neutral $90
Jan-03-19Downgrade BofA/Merrill Neutral → Underperform
Dec-03-18Downgrade BofA/Merrill Buy → Neutral
Nov-30-18Downgrade Goldman Buy → Neutral
Mar-01-21 12:42AM  
Feb-26-21 03:40PM  
12:27PM  
Feb-24-21 04:28PM  
07:30AM  
Feb-23-21 08:30AM  
06:20AM  
Feb-17-21 02:47PM  
Feb-16-21 12:51PM  
06:45AM  
Feb-09-21 03:30PM  
Feb-06-21 07:30AM  
03:13AM  
Feb-04-21 04:30PM  
11:25AM  
08:05AM  
07:26AM  
06:54AM  
06:45AM  
06:35AM  
06:30AM  
Feb-03-21 04:19PM  
Feb-01-21 11:27AM  
09:46AM  
Jan-29-21 11:34AM  
05:57AM  
Jan-28-21 12:32PM  
10:08AM  
Jan-26-21 03:28PM  
Jan-22-21 06:35AM  
Jan-20-21 06:18AM  
Jan-19-21 10:17AM  
Jan-18-21 01:46PM  
09:49AM  
07:34AM  
07:01AM  
Jan-14-21 11:51AM  
07:48AM  
Jan-13-21 03:18PM  
10:35AM  
09:52AM  
Jan-11-21 05:45PM  
Jan-06-21 12:10PM  
Jan-05-21 05:50PM  
Jan-01-21 11:30AM  
Dec-30-20 07:14AM  
Dec-29-20 05:50PM  
Dec-28-20 10:55AM  
Dec-23-20 12:55AM  
Dec-22-20 11:50AM  
11:40AM  
06:45AM  
Dec-21-20 05:45PM  
Dec-17-20 05:40PM  
03:07PM  
07:05AM  
Dec-16-20 07:01AM  
06:45AM  
Dec-14-20 05:45PM  
02:39PM  
Dec-09-20 11:23AM  
08:03AM  
Dec-07-20 12:02PM  
Dec-02-20 11:59PM  
10:40AM  
Nov-25-20 08:59AM  
Nov-24-20 07:30AM  
Nov-23-20 06:39PM  
06:45AM  
Nov-21-20 11:30AM  
Nov-18-20 06:30PM  
11:06AM  
Nov-17-20 12:06PM  
Nov-13-20 05:58AM  
Nov-11-20 10:28AM  
Nov-03-20 01:58PM  
Nov-02-20 07:47AM  
Oct-28-20 07:30PM  
10:58AM  
10:01AM  
Oct-27-20 11:09AM  
07:30AM  
Oct-26-20 10:05PM  
Oct-24-20 10:04AM  
Oct-22-20 04:34PM  
04:30PM  
02:22PM  
01:14PM  
01:08PM  
01:08PM  
10:43AM  
08:05AM  
07:15AM  
07:08AM  
06:45AM  
Oct-21-20 08:40AM  
Oct-17-20 06:43AM  
01:08AM  
Oct-16-20 09:58AM  
09:57AM  
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated has a strategic collaboration with hc1; and strategic relationships with Clinical Genomics Pty Ltd and Anthem Inc. The company was founded in 1967 and is headquartered in Secaucus, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PREVOZNIK MICHAEL ESVP & General CounselFeb 25Sale115.4980192,50740,152Mar 01 04:29 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 24Sale116.951,188138,93740,953Feb 25 04:39 PM
GUINAN MARKExecutive Vice President & CFODec 24Option Exercise66.5181,7565,437,592155,335Dec 28 04:27 PM
GUINAN MARKExecutive Vice President & CFODec 24Sale120.3781,7569,840,67373,579Dec 28 04:27 PM
WILENSKY GAIL RDirectorNov 24Option Exercise57.676,111352,39122,593Nov 27 04:38 PM
WILENSKY GAIL RDirectorNov 24Sale126.026,111770,12016,482Nov 27 04:38 PM
STANZIONE DANIELDirectorNov 23Sale126.3011,2231,417,45928,349Nov 24 04:31 PM
DEPPE MICHAEL JVP, Corp. Controller & CAOOct 21Option Exercise57.2510,450598,24435,485Oct 23 04:42 PM
DEPPE MICHAEL JVP, Corp. Controller & CAOOct 21Sale125.0010,4501,306,25025,090Oct 23 04:42 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentOct 16Option Exercise66.51291,99719,420,720529,744Oct 19 04:17 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentOct 16Sale120.00291,99735,039,640237,747Oct 19 04:17 PM
PREVOZNIK MICHAEL ESVP & General CounselOct 14Option Exercise52.1735,5911,856,60575,678Oct 15 04:45 PM
PREVOZNIK MICHAEL ESVP & General CounselOct 14Sale119.0035,5914,235,32940,087Oct 15 04:45 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Sep 02Option Exercise66.5158,3923,883,652126,803Sep 04 04:18 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Sep 02Sale110.6058,3926,458,34368,411Sep 04 04:18 PM
RING TIMOTHY MDirectorJun 08Option Exercise58.5011,730686,20932,235Jun 10 04:31 PM
GUINAN MARKExecutive Vice President & CFOJun 08Option Exercise71.1772,5965,166,657146,175Jun 10 04:33 PM
GUINAN MARKExecutive Vice President & CFOJun 08Sale117.2372,5968,510,58573,579Jun 10 04:33 PM
RING TIMOTHY MDirectorJun 08Sale116.6011,7301,367,71820,505Jun 10 04:31 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentApr 27Option Exercise71.1711,717833,899249,464Apr 28 04:45 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentApr 27Sale112.0111,7171,312,433237,747Apr 28 04:45 PM
EGLINTON MANNER CARRIESVP, Advanced DiagnosticsApr 27Sale111.025,000555,07522,390Apr 28 04:37 PM
Davis J. E.EVP, General DiagnosticsMar 16Sale87.753,513308,25138,086Mar 17 04:37 PM
PREVOZNIK MICHAEL ESVP & General CounselMar 11Sale104.252,175226,74440,087Mar 12 05:00 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Mar 11Sale104.252,501260,72968,411Mar 12 04:57 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 10Option Exercise71.171007,117237,847Mar 12 04:55 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 10Sale112.1910011,219237,747Mar 12 04:55 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 06Option Exercise71.17230,17816,381,768456,738Mar 10 04:38 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 06Sale112.67230,17825,934,978226,560Mar 10 04:38 PM